Ascend Wellness Announces Opening of a New Dispensary in Wharton, New Jersey
Ascend Wellness Holdings (AAWH) announced the relocation of its Montclair dispensary to a new location in Wharton, New Jersey, set to open on June 28, 2024. This new facility spans approximately 3,000 square feet and features 13 sales terminals, six kiosks, two ATMs, and ample parking. The dispensary will serve both medical and adult-use cannabis customers, offering a wide range of products including flowers, vaporizers, concentrates, ingestibles, topicals, and accessories, along with a drive-thru service. The move aims to cater to the growing New Jersey market and enhance customer convenience. A grand opening celebration will be held on June 28, 2024, allowing attendees to explore the new store and meet the Ascend team.
- Relocation to a 3,000 sq. ft. facility enhances service capacity.
- Introduction of a drive-thru for increased customer convenience.
- 13 sales terminals and six kiosks reduce wait times.
- Serving both medical and adult-use cannabis customers expands market reach.
- Grand opening event fosters community engagement.
- Relocation may incur significant costs and operational disruptions.
~ Grand Opening Slated for June 28, 2024 ~
The Ascend Wharton dispensary offers both medical and adult-use customers in the
"The opening of Ascend's
To celebrate the opening of the
Spanning approximately 3,000 square feet, the
Ascend customers can also join the free Ascenders Club, where shopping becomes even more rewarding. Highlights include earning 1 point for every
Ascend Wharton is located at 325 NJ-15 in
For more information about Ascend and its dispensaries, visit www.awholdings.com.
AWH is a vertically integrated operator with assets in
This news release includes forward-looking information and statements, which may include, but are not limited to, the plans, intentions, expectations, estimates, and beliefs of the Company. Words such as "expects", "continue", "will", "anticipates" and "intends" or similar expressions are intended to identify forward-looking information and statements. Without limiting the generality of the preceding statement, this news release contains forward-looking information and statements concerning the Company's current projections and expectations about future events and financial trends, the timely receipt of all required regulatory approvals, and the general stability of the economic and political environment. We caution investors that any such forward-looking information and statements are based on certain assumptions and analysis made by the Company in light of the experience of the Company and its perception of historical trends, current conditions and expected future developments, and other factors management believes are appropriate.
Forward-looking information and statements involve and are subject to assumptions and known and unknown risks, uncertainties, and other factors which may cause actual events, results, performance, or achievements of the Company to be materially different from future events, results, performance, and achievements expressed or implied by forward-looking information and statements herein. Such factors include, among others, the risks and uncertainties identified in the Company's Annual Report on Form 10-K for the year ended December 31, 2023, and in the Company's other reports and filings with the applicable Canadian securities regulators on its profile on SEDAR+ at www.sedarplus.ca and with the SEC on its profile on EDGAR at www.sec.gov. Although the Company believes that any forward-looking information and statements herein are reasonable, in light of the use of assumptions and the significant risks and uncertainties inherent in such information and statements, there can be no assurance that any such forward-looking information and statements will prove to be accurate, and accordingly readers are advised to rely on their own evaluation of such risks and uncertainties and should not place undue reliance upon such forward-looking information and statements. Any forward-looking information and statements herein are made as of the date hereof, and except as required by applicable laws, the Company assumes no obligation and disclaims any intention to update or revise any forward-looking information or statements herein or to update the reasons that actual events or results could or do differ from those projected in any forward-looking information and statements herein, whether as a result of new information, future events or results, or otherwise, except as required by applicable laws.
The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this news release.
View original content to download multimedia:https://www.prnewswire.com/news-releases/ascend-wellness-announces-opening-of-a-new-dispensary-in-wharton-new-jersey-302177307.html
SOURCE Ascend Wellness Holdings, Inc.
FAQ
When is the Ascend Wellness dispensary in Wharton, NJ opening?
What products will be available at the Ascend Wharton dispensary?
Does the Ascend Wharton dispensary have a drive-thru?
What are the operating hours for the Ascend Wharton dispensary?